Current practices in laboratory monitoring of HIV infection
After a diagnosis of HIV infection is made, the patient needs to be monitored using both clinical assessment and laboratory markers. HIV/AIDS monitoring is essential in guiding when to recommend initiation of therapy. Clinical monitoring will include staging of the HIV/AIDS disease using either the...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications & Media Pvt Ltd
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284091/ |
| id |
pubmed-3284091 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-32840912012-02-24 Current practices in laboratory monitoring of HIV infection Vajpayee, Madhu Mohan, Teena Review Article After a diagnosis of HIV infection is made, the patient needs to be monitored using both clinical assessment and laboratory markers. HIV/AIDS monitoring is essential in guiding when to recommend initiation of therapy. Clinical monitoring will include staging of the HIV/AIDS disease using either the presence or absence of HIV-related signs and symptoms using the WHO staging system. Various laboratory methods can be used to monitor the disease progression and to guide whether the patient will need antiretroviral therapy or not. Laboratory monitoring for patients who are not on drugs is done to provide information about the stage of illness; to enable the clinician to make decisions on treatment and to give information on prognosis of the patient. Patients on drugs are monitored to assess their response to treatment with antiretroviral drugs and to detect any possible toxicity and improvement associated with the antiretroviral drugs. Medknow Publications & Media Pvt Ltd 2011-12 /pmc/articles/PMC3284091/ /pubmed/22310815 http://dx.doi.org/10.4103/0971-5916.92627 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Vajpayee, Madhu Mohan, Teena |
| spellingShingle |
Vajpayee, Madhu Mohan, Teena Current practices in laboratory monitoring of HIV infection |
| author_facet |
Vajpayee, Madhu Mohan, Teena |
| author_sort |
Vajpayee, Madhu |
| title |
Current practices in laboratory monitoring of HIV infection |
| title_short |
Current practices in laboratory monitoring of HIV infection |
| title_full |
Current practices in laboratory monitoring of HIV infection |
| title_fullStr |
Current practices in laboratory monitoring of HIV infection |
| title_full_unstemmed |
Current practices in laboratory monitoring of HIV infection |
| title_sort |
current practices in laboratory monitoring of hiv infection |
| description |
After a diagnosis of HIV infection is made, the patient needs to be monitored using both clinical assessment and laboratory markers. HIV/AIDS monitoring is essential in guiding when to recommend initiation of therapy. Clinical monitoring will include staging of the HIV/AIDS disease using either the presence or absence of HIV-related signs and symptoms using the WHO staging system. Various laboratory methods can be used to monitor the disease progression and to guide whether the patient will need antiretroviral therapy or not. Laboratory monitoring for patients who are not on drugs is done to provide information about the stage of illness; to enable the clinician to make decisions on treatment and to give information on prognosis of the patient. Patients on drugs are monitored to assess their response to treatment with antiretroviral drugs and to detect any possible toxicity and improvement associated with the antiretroviral drugs. |
| publisher |
Medknow Publications & Media Pvt Ltd |
| publishDate |
2011 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284091/ |
| _version_ |
1611507613448536064 |